Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
A study published in Maturitas found that postmenopausal women have distinct gut microbiome patterns compared to premenopausal women, affecting estrogen metabolism and related health outcomes including cardiovascular health and bone density
Their tendency to cause weight loss is thrusting them into a significant role in the management of obesity
CHF6001 II: a novel phosphodiesterase 4 inhibitor, suitable for topical pulmonary administration-in vivo preclinical pharmacology profile defines a potent anti-inflammatory compound with a wide therapeutic window
Also referred to as the mother of all antioxidants, this brings with it both benefits and side effects
US$ 28.05
US$ 24.20
US$ 26.55
